MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026)

MoonLake Immunotherapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $33.0 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 42.39% year-over-year to $33.0 million in Q1 2026; TTM through Mar 2026 was $33.0 million, a 42.39% increase from a year earlier, with the FY2025 full-year figure at $22.9 million, down 2.4% from the prior year.
• Prepaid Assets advanced to $33.0 million in Q1 2026 per MLTX's latest filing, from $22.9 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $33.0 million in Q1 2026 and bottomed at $135916.0 in Q1 2022.
• The 5-year median for Prepaid Assets is $5.1 million (2022), against an average of $12.9 million.
• Biggest YoY gain for Prepaid Assets was 2415.82% in 2022; the steepest drop was 53.07% in 2022.
• Year by year, Prepaid Assets stood at $4.2 million in 2022, then sank by 49.7% to $2.1 million in 2023, then soared by 1013.97% to $23.4 million in 2024, then retreated by 2.4% to $22.9 million in 2025, then soared by 44.19% to $33.0 million in 2026.
• Per Business Quant, the three latest MLTX Prepaid Assets figures stand at $33.0 million (Q1 2026), $22.9 million (Q4 2025), and $26.7 million (Q3 2025).